Loading...

Aptorum Group Limited

APM•NASDAQ
Healthcare
Biotechnology
$0.90
$0.010(1.11%)
U.S. Market opens in 15h 19m

Aptorum Group Limited (APM) Stock Overview

Explore Aptorum Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.7M
P/E Ratio-4.80
EPS (TTM)$-0.19
ROE-0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$0.64
3 Months$1.09
1 Year Target$0.00

APM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aptorum Group Limited (APM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.80 and a market capitalization of 5.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.11%
5-Day Change
3.07%
1-Month Change
-16.68%
3-Month Change
-8.57%
6-Month Change
-39.60%
Year-to-Date (YTD) Change
-15.10%
1-Year Change
-1.43%
3-Year Change
-69.39%
5-Year Change
-96.44%
All-Time (Max) Change
-99.37%

Contact Information

https://www.aptorumgroup.com
44 20 8092 9299
17 Hanover Square, London, NaN, W1S 1BN

Company Facts

1 Employees
IPO DateDec 18, 2018
CountryGB
Actively Trading

Frequently Asked Questions